Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phosphate Lowering to Treat Vascular Dysfunction in CKD
NCT02209636Phase 4Completed
- Sponsor
- VA Office of Research & Development
- Start
- Sep 2014
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lanthanum carbonate in chronic kidney disease (CKD), sponsored by VA Office of Research & Development. Started Sep 2014; status: completed.
02
Drugs
lanthanum carbonate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02209636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02209636.